1.
P659. A feasibility study with the telemedicine tool MyBiologicalCoach in The Netherlands
2.
P695. Use of infliximab and associated costs in inflammatory bowel disease patients: an analysis of real-life health claims data in the Netherlands
P696. First results and information model from the Parelsnoer Institute IBD biobank: a nationwide standardised inflammatory bowel disease collection by all university medical centr...
P132 Cooperation to improve quality of IPAA surgery in IBD: south Netherlands experience
P328 Faecal microbiota transplantation as treatment for recurrent Clostridiodes difficile infection in patients with inflammatory bowel disease: Experiences of the Netherlands dono...
The diagnostic yield of open-access endoscopy of the upper gastrointestinal tract in the Netherlands
3.
4.
P525 Patients’ Perception of Risks of biologic therapy During Covid-19 Pandemic in Israel Orly Lior, Ilia Sergeev, Nahum Ruhimovich, Michal Openheim, Fabiana Benjaminov, Dan Feldma...
The Severity of Fecal Problems Is Negatively Associated With Quality of Life in a Dutch Population Without Bowel Function Comorbidities
High prevalence of low bone mineral density in patients with Inflammatory Bowel Disease in the setting of a peripheral Dutch hospital
Disease severity does not affect the interval between IBD diagnosis and the development of CRC: Results from two large, Dutch case series